Genes identified in <i>esp1-1</i> SL and SDL screens implicated in Ty1 and Ty3 transposition. by Krystina L. Ho (714635)

“…<p>^aMutants that suppress the hypertransposition phenotype of <i>rtt101Δ</i> and <i>med1Δ</i> mutants [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref045" target="_blank">45</a>]</p><p>^bMutants that increase the Ty1 transposition frequency [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref042" target="_blank">42</a>]</p><p>^cAll mutants have decreased Ty1 transposition except for 2 (<i>YML105C</i> and <i>YOL159C</i>) [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref040" target="_blank">40</a>]</p><p>^dP-body components encoded by <i>DHH1</i>, <i>KEM1</i>, <i>LSM1</i>, and <i>PAT1</i> act as cofactors that posttranscriptionally enhance Ty1 retrotransposition [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref044" target="_blank">44</a>]</p><p>^eDeletion of <i>HOS2</i> or <i>SET3</i> reduces Ty1 transposition [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref101" target="_blank">101</a>]</p><p>^f<i>rtt</i> mutants have increased levels of Ty1 transposition [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref043" target="_blank">43</a>]</p><p>^g<i>rad50</i>, <i>rad51</i>, <i>rad52</i>, <i>rad54</i> and <i>rad57</i> mutants have increased Ty1 transposition [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref058" target="_blank">58</a>]</p><p>^h<i>spt</i> mutants suppress <i>lys2-128δ</i> and <i>his4-917</i> Ty insertion mutations [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref049" target="_blank">49</a>]</p><p>ⁱ<i>SPT23</i> is a high copy suppressor of the <i>his4-912δ</i> and <i>lys2-61</i> Ty induced Promoter mutations [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref048" target="_blank">48</a>]</p><p>^jThe mating pheromone-response pathways suppresses Ty1 transposition[<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref102" target="_blank">102</a>]</p><p>^kMutants that increase or decrease Ty3 transposition frequency [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005109#pgen.1005109.ref041" target="_blank">41</a>]</p><p>Genes identified in <i>esp1-1</i> SL and SDL screens implicated in Ty1 and Ty3 transposition.…”

Virtual magnetic intensity map (VMI-map) and generation of individual tracks by pigeons inside this map. by Cordula V. Mora (456425)

“…Thus, the maximum increase or decrease in intensity experienced for a 15-s trial, achieved by the pigeon sitting in front of either of the feeders associated with magnetic intensity increases or decreases respectively, was ±12,500 nT. …”

Analysis of the second dimension of the rate-yield tradeoff. by Chuankai Cheng (6791417)

“…<p>In (A) and (B), the growth rate of each ALE endpoint strain is labeled as black number beside the corresponding data point. …”

Shifts in RCP during murine embryonic and germ-cell development. by Minseung Choi (4574236)

“…RCP point estimates and approximate 95% bias-corrected bootstrap confidence intervals are given in the associated tables and in (c). <b>(a)</b> Transitions from early pronuclear stages (1 and 3) to late stages (4-5) were accompanied by a sharp decrease in RCP at <i>L1</i> elements, to a level similar to that observed in cultured stem cells (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1007060#pgen.1007060.g003" target="_blank">Fig 3</a>). …”

Table_3_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

Table_1_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

Table_5_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

Data_Sheet_1_Associations of Renalase With Blood Pressure and Hypertension in Chinese Adults.docx by Yang Wang (5921)

“…Serum renalase levels and BPs showed a linear correlation. In addition, serum renalase was significantly associated with the risk of hypertension [OR = 1.018 (1.006–1.030)]. ③ The expression of renalase in human renal biopsy specimens significantly decreased in hypertensive patients compared to non-hypertensive patients (0.030 ± 0.001 vs. 0.038 ± 0.004).…”

Cross-Conjugated Systems Based On An (<i>E</i>)‑Hexa-3-en-1,5-diyne-3,4-diyl Skeleton: Spectroscopic and Spectroelectrochemical Investigations by Josef B. G. Gluyas (1478950)

“…The linear optical absorption properties can be tuned by modification of the substituents at the 1 and 5 positions of the hexa-3-en-1,5-diynyl backbone (<b>1</b>: Si­(CH­(CH₃)₂)₃, <b>2</b>: C₆H₄CCSi­(CH₃)₃, <b>3</b>: C₆H₄COOCH₃, <b>4</b>: C₆H₄CF₃, <b>5</b>: C₆H₄CN, <b>6</b>: C₆H₄CCC₅H₄N), although attempts to introduce electron-donating (C₆H₄CH₃, C₆H₄OCH₃, C₆H₄Si­(CH₃)₃) substituents at these positions were hampered by the ensuing decreased stability of the compounds. …”

Table_2_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

Table_7_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

Cross-Conjugated Systems Based On An (<i>E</i>)‑Hexa-3-en-1,5-diyne-3,4-diyl Skeleton: Spectroscopic and Spectroelectrochemical Investigations by Josef B. G. Gluyas (1478950)

“…The linear optical absorption properties can be tuned by modification of the substituents at the 1 and 5 positions of the hexa-3-en-1,5-diynyl backbone (<b>1</b>: Si­(CH­(CH₃)₂)₃, <b>2</b>: C₆H₄CCSi­(CH₃)₃, <b>3</b>: C₆H₄COOCH₃, <b>4</b>: C₆H₄CF₃, <b>5</b>: C₆H₄CN, <b>6</b>: C₆H₄CCC₅H₄N), although attempts to introduce electron-donating (C₆H₄CH₃, C₆H₄OCH₃, C₆H₄Si­(CH₃)₃) substituents at these positions were hampered by the ensuing decreased stability of the compounds. …”

Table_4_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

DataSheet1_Transcriptomic profiles of age-related genes in female trachea and bronchus.pdf by Jia Liu (41593)

“…</p><p>Conclusion: We found the proportion of basal cells decreased with age in both the trachea and bronchus, suggesting a weakening of their self-renew ability with age. …”

Table_6_Verification of Resveratrol Inhibits Intestinal Aging by Downregulating ATF4/Chop/Bcl-2/Bax Signaling Pathway: Based on Network Pharmacology and Animal Experiment.xls by Tian-hao Liu (9109460)

“…Herein, we aimed to further explore the pharmacological mechanisms of resveratrol as a therapy for intestinal aging. We performed network construction and enrichment analysis via network pharmacology. …”

X-ChIP based affinity purification provides the most inclusive analysis of nucleoid associated proteins. by Nina Rajala (693865)

“…The pie-chart shown here illustrates the distribution of the 366 enriched proteins identified with the X-ChIP method in regular HEK293 TwinkleFLAG and measured in HEK293 TwinkleFLAG ρ° in the following classes: not detected (absent), 95 proteins; ≥2 fold decrease, 163 proteins; no change, 100 proteins or ≥2 fold increase, 8 proteins(see also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116726#pone.0116726.s004" target="_blank">S3 Table</a>). …”

CONSORT 2010 flow diagram. by Mario Daidone (18692907)

“…Moreover, these findings provide an additional plausible interpretation of the results from observational and cohort studies linking high adherence to a Mediterranean-style diet with lower total mortality and a decrease in cardiovascular events and cardiovascular mortality.…”

Mapping the properties of cells in relation to their local neighborhood. by Matthew French (13007466)

“…This shows a decrease in NR, indicating TBX6+ high cells are surrounded by cells expressing lower TBX6 levels than expected within a random pattern. …”

Suppression of APP maturation and proteolytic metabolism by the PDZ domains of X11 proteins. by Yuhki Saito (145216)

“…Data were analyzed using the Student's <i>t</i>-test (*, <i>P</i><0.05; **, <i>P</i><0.01; ***, <i>P</i><0.001). Proteins showing a significant decrease (P<0.01 and P<0.001) in Aβ generation are shown as closed columns.…”

Hexadentate Hydroxypyridonate Iron Chelators Based on TREN-Me-3,2-HOPO:  Variation of Cap Size¹ by Jide Xu (1446652)

“…The incremental enlargement of ligand size results in a decrease in iron-chelate stability, as reflected in the log β₁₁₀ values of 26.8, 26.2, 26.42, and 24.48 for the TREN, TR322, TR332, and TRPN derivatives, respectively. …”